GlaxoSmithKline and Access to Essential Medicines (B)

&
Journal of Business Ethics Education 2 (1):123-132 (2005)
  Copy   BIBTEX

Abstract

The (B) case summarizes GSK’s response to pressures to increase access to essential medicines in developing countries and subsequent developments.

Categories

Keywords

Reprint years

ISBN(s)

16495195

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Montréal Statement on the Human Right to Essential Medicines.Thomas Pogge - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (1):97-108.
Supply of medicines: paternalism, autonomy and reality.D. Prayle & M. Brazier - 1998 - Journal of Medical Ethics 24 (2):93-98.
Improving access to essential medicines: How health concerns can be prioritised in the global governance system.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Race against time: The export of essential medicines to rwanda.Matthew Rimmer - 2008 - Public Health Ethics 1 (2):89-103.
Access to Medicines in Developing Countries: Ethical Demands and Moral Economy.Marilena Correa Maurice Cassier - 2014 - Developing World Bioethics 14 (2):ii-viii.
Introduction: Access to Life-Saving Medicines and Intellectual Property Rights.Doris Schroeder - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):277-278.
Trade Rules, Intellectual Property, and the Right to Health.Lisa Forman - 2007 - Ethics and International Affairs 21 (3):337-357.
Bodies of rights and therapeutic markets.João Biehl & Adriana Petryna - 2011 - Social Research: An International Quarterly 78 (2):359-386.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation.Rudolf V. Van Puymbroeck - 2010 - Journal of Law, Medicine and Ethics 38 (3):520-549.

Analytics

Added to PP
2012-03-18

Downloads
55 (#284,290)

6 months
10 (#251,846)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Moral Luck and Business Ethics.Christopher Michaelson - 2008 - Journal of Business Ethics 83 (4):773-787.
BB&T, Atlas Shrugged.S. Douglas Beets - 2015 - Journal of Academic Ethics 13 (4):311-344.

Add more citations

References found in this work

No references found.

Add more references